Study guide / common questions
Tesamorelin FAQ
Short answers cover tesamorelin, body fat, safety, and FDA approval. Each one starts with the people studied and ends at the proof limit.
What is tesamorelin made to do?
Tesamorelin is a 44-amino-acid copy of a brain hormone. Amino acids are the small pieces joined to make a protein.
The drug starts growth hormone release from the gland and raises IGF-1 [4][1]. FDA approval came in 2010 only for the belly-fat illness tied to HIV [5].
What body change does tesamorelin start first?
The growth gland first releases growth hormone [4]. The liver then makes IGF-1, a growth protein that helps break down belly fat.
In the approved HIV use, belly fat fell 15.2%. It rose 5.0% with placebo [1].
Did tesamorelin lower belly fat in the main trial?
The key trial gave adults with HIV tesamorelin 2 mg/day. Their deep belly fat fell 15.2%, while placebo rose 5.0% [1].
No broad fat-loss trial has covered the public [5]. You can't assume the HIV finding applies to you.
When did studies check the belly-fat change?
Researchers first checked belly fat at 26 weeks. At week 52, it remained 18% below the start [2].
A 2024 trial of newer HIV drugs checked change over 12 months [10]. Everyone in that trial still had HIV.
Did tesamorelin lower deep fat but leave skin fat?
Across the 52-week HIV work, belly fat stayed 18% below the start [2]. Fat under the skin remained [1].
A 2026 review also confirmed lower deep belly fat [12]. Its 95% range still showed a drop at the low end.
How much deep belly fat did studies find?
The key HIV trial found a 15.2% drop over 26 weeks [1]. At week 52, the drop remained 18% [2].
A 2026 review also found less deep belly fat [12]. These findings don't come from ordinary weight-loss trials.
What happened after tesamorelin stopped?
Belly fat began returning when the drug stopped. The 52-week work found the earlier change reversed [2].
The drug therefore wasn't a one-time fix. The effect lasted only while treatment continued.
Could tesamorelin become a fatty-liver treatment?
The 12-month trial had only 61 people, all with HIV. Tesamorelin 2 mg/day cut liver fat 37% more than placebo.
Also, 35% fell below 5% liver fat, versus 4% with placebo [6]. More study is needed, and broad liver use isn't approved.
What changed in liver samples after tesamorelin?
After 12 months, liver cells had turned up genes that help burn fat [8]. They turned down genes tied to swelling and scars.
That may explain the drop in liver fat. It doesn't prove better liver health years later.
Did several tesamorelin liver studies find less fat?
A 6-month trial of 50 adults found 2.9% less liver fat [3]. Five trials were later joined in a 2026 review.
That review reached the same result [12]. Everyone studied lived with HIV and had fatty liver.
How does tesamorelin work inside the body?
Tesamorelin makes the growth gland send growth hormone in brief waves [4]. Next, the liver makes IGF-1, a growth protein.
In 13 healthy men, IGF-1 rose 181 micrograms per liter [4]. No normal range appears here, so that figure can't show safe or unsafe.
Does tesamorelin contain growth hormone?
No, the growth gland sends out the body's own hormone after tesamorelin. Growth hormone isn't inside the drug.
Healthy men had more growth hormone overnight. IGF-1, their liver-made protein, rose 181 micrograms per liter [4].
How does tesamorelin start growth hormone release?
Tesamorelin locks onto the outside of cells in the growth gland [4]. Those cells answer with brief growth-hormone waves.
One added piece shields the drug from a cutting enzyme [4]. That delay gives the growth gland time to respond.
How much did IGF-1 rise with tesamorelin?
The main HIV trial reported an 81.0% IGF-1 rise [1]. In a small study, the rise was 181 micrograms per liter over two weeks [4].
This liver-made growth protein may help explain belly-fat loss. The IGF-1 growth effect also explains the active-cancer warning [5].
What happened to blood sugar with tesamorelin?
In 13 healthy men, two blood sugar checks showed no clear change over two weeks [4]. The 52-week HIV work also found no important change [2].
People with high blood sugar still need care. That question belongs with your doctor and your blood tests.
Can tesamorelin make the body hold water?
Yes, extra water may stay in the body when growth hormone rises. Tesamorelin also raises IGF-1, a liver-made growth protein.
This effect is part of its known safety record. It was usually mild in the trials [2].
Which tesamorelin side effects came up most often?
A major review found no known liver harm from tesamorelin [5]. Trials found soreness, redness, and small blood sugar changes [2].
The IGF-1 rise matters for cancer risk. Active cancer and pregnancy bar the drug [5].
Who cannot receive tesamorelin under the label?
The FDA label bars tesamorelin during active cancer [5]. It also bars the drug during pregnancy or with a known allergy.
Animal studies found harmful brain fluid in the offspring. Organized sport also bars tesamorelin because it raises growth hormone.
Has tesamorelin proved fat loss outside HIV?
Adults taking HIV medicines made up the main fat-loss trials [1][2]. Broad proof for those without HIV is missing.
Outside HIV, one small study included healthy men [4]. Another checked thinking skills, not ordinary weight loss.
What does tesamorelin half life mean here?
Half-life is the time for half the drug to leave blood. One study's math put clearance at 1,060 liters an hour [15].
That rate isn't blood pumped or lost. The FDA label and Mayo Clinic give 26-38 minutes, while the later IGF-1 effect lasts longer [4].
How long does tesamorelin act after the shot?
The study's removal-rate estimate was 1,060 liters an hour [15]. This math rate is not a volume of blood leaving your body.
Other sources say half remains for 26-38 minutes. Its later IGF-1 effect can last through the day [4].
Is tesamorelin FDA approved for every use?
No, approval came in 2010 only for adults with HIV and excess belly fat [5]. The illness moves body fat to the wrong places.
Ordinary weight loss, anti-aging, and sports aren't approved uses. The FDA hasn't approved tesamorelin for those purposes.
Which health risks matter before tesamorelin?
Pregnancy and active cancer both bar tesamorelin under the FDA label [5]. A known drug allergy also bars it.
High blood sugar calls for added care and blood tests [2]. Its growth-hormone effect also bars it from organized sport.